Opening up the World of Drug Discovery: Assay Depot's Kevin LustigSubmitted by Theral Timpson on Sun, 04/29/2012 - 20:43
Podcast brought to you by: Geschickten Biosciences the world’s first biology knowledge discovery services company focused on democratizing NGS data analyses. To manage, analyze and visualize your NGS data please login to interpretomics.co
Kevin Lustig, PhD, CEO, Assay Depot Bio and Contact Info
Opening up the World of Drug Discovery: Kevin Lustig, Assay Depot from mendelspod on Vimeo.
Listen (4:33) Assay Depot
Listen (6:33) What took so long to get an Amazon for the life sciences?
Listen (7:18) Empowering individual scientists
Listen (3:33) What is a programmable lab?
Listen (5:55) Drug development from the beach at Waikiki
Listen (2:07) Open Science Challenge
As the pharma industry moves toward more outsourcing and virtual business structures, a new online exchange has emerged as a popular platform for life science transactions. AssayDepot.com has been called by Atul Butte, bioinformatics professor at Stanford, a Home Depot for science. In today's show we talk with the co-founder and CEO of Assay Depot, Kevin Lustig. Originally Kevin and his colleague created the site to complement what was going to be a new CRO in San Diego. Soon they realized the site itself, with features borrowed from Amazon, Kayak, and Google, offered a greater business opportunity than another CRO. Kevin talks about the platform and its various features and at large about new trends in pharma.